Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Chronic Hepatitis C Virus Infection With Direct Acting Antivirals in Kidney Transplant Recipients

NCT03880682 is registered in ClinicalTrials.gov with Istanbul University as lead sponsor.

NCT NCT03880682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03880682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Chronic Hepatitis C Virus Infection With Direct Acting Antivirals in Kidney Transplant Recipients
Lead sponsor
Istanbul University
Phase
Observational
Overall status
Completed
Start date
November 1, 2018
Completion date
October 31, 2019
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c, chronic, kidney transplant; complications